作者: Takashi Kurita
DOI: 10.1016/S1880-4276(07)80030-5
关键词: Heart disease 、 Medicine 、 Myocardial infarction 、 Disease 、 Implantable cardioverter-defibrillator 、 Mortality rate 、 Randomized controlled trial 、 Cardiology 、 Sudden cardiac death 、 Internal medicine 、 Clinical trial
摘要: Recently several randomized trials have demonstrated the excellent role of implantable cardioverter-defibrillator (ICD) in improving mortality rate patients with a high risk sudden cardiac death regardless its purpose or underlying heart disease. However, because such large clinical only been carried out Western countries, those results may not be fully applicable to Japanese other Asian patient populations. According study, total was approximately 20% during 5 years follow up, which comparable to, slightly better than that MADIT-II ICDs. In population an prognosis, criteria can easily applied. Therefore, we should strengthen criteria, i.e. from EF ≤ 35% 25% adopt usage additional examinations (e.g. signal averaging ECG, micro-volt T wave alternance EPS).